Kathleen Nadine Moore

40PUBLICATIONS
234CO-AUTHORS
Cancer geneticsMolecular targetsCancer therapy (excl. chemotherapy and radiation therapy)Predictive and prognostic markersPharmacogenomics
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (40)

|Jul 17, 2026
Accurate data as the foundation of equitable cancer control: Lessons from global cancer statistics 2024 and the complexity of ovarian cancer.

|Jun 17, 2026
Antibody-drug conjugates in gynaecological cancers: opportunities and challenges.

|Jun 17, 2026
New standards and new constraints redefine treatment sequencing in platinum-resistant ovarian cancer.

|Dec 11, 2025
Molecular Profiling and Tumor Biomarker Analysis of GOG281/LOGS: A Positive Late-Phase Trial of Trametinib for Recurrent/Persistent Low-Grade Serous Ovarian Carcinoma.

Robert L Hollis, Austin Miller, Heather A Lankes

|Oct 31, 2025
Decoding the End Points of Poly (ADP-ribose) Polymerase Inhibitor Trials in Ovarian Cancer.

Bradley J Monk, Robert L Coleman, David M O'Malley

|Jul 11, 2025
Efficacy and Safety of Avutometinib ± Defactinib in Recurrent Low-Grade Serous Ovarian Cancer: Primary Analysis of ENGOT-OV60/GOG-3052/RAMP 201.

Susana N Banerjee, Els Van Nieuwenhuysen, Carol Aghajanian

Pageof 7

Frequent Collaborators

8 joint publications

Bradley J Monk

5 joint publications

Susana N Banerjee

5 joint publications

Michael Bookman

5 joint publications

Antonio González-Martín